Stay updated on Exenatide Once Weekly in Adolescent Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Exenatide Once Weekly in Adolescent Type 2 Diabetes Clinical Trial page.

Latest updates to the Exenatide Once Weekly in Adolescent Type 2 Diabetes Clinical Trial page
- ChecktodayChange DetectedThe footer now identifies the ClinicalTrials.gov release as v3.8.0 instead of v3.7.2; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAn NIH website-transition announcement now appears above the 403 error message, and the displayed site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check28 days agoChange DetectedThe ClinicalTrials.gov error page’s footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check42 days agoChange DetectedDeleted the Study Documents section (CSR Synopsis, CSP, SAP and related links) and the sponsor/IPD sharing details. The full list of study locations and contacts was removed from the page.SummaryDifference19%

- Check49 days agoChange DetectedRevision metadata updated from v3.6.6 to v3.7.0. This reflects a backend or documentation update with no visible changes to the study page content.SummaryDifference0.0%

- Check63 days agoChange DetectedThe revision tag on the page was updated from v3.6.5 to v3.6.6, indicating a small update to the study record display.SummaryDifference0.0%

Stay in the know with updates to Exenatide Once Weekly in Adolescent Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Exenatide Once Weekly in Adolescent Type 2 Diabetes Clinical Trial page.